David E. Goldgar, PhD
- Departments: Dermatology - Research Professor, Family & Preventive Medicine - Adjunct Professor
- Divisions: Physician Assistant Program
- Cancer Center Programs: Cancer Control & Population Sciences
Academic Office Information
Huntsman Cancer Institute
2000 Circle of Hope
Salt Lake City, UT 84112
David Goldgar, PhD, is a research professor in the Department of Dermatology at the University of Utah and member of the Cancer Control and Population Sciences (CCPS) Program at Huntsman Cancer Institute.
Goldgar's research involves the genetic study of breast cancer and melanoma. He studies methods to clinically classify the BRCA1 and BRCA2 genes, the most well-known genes for breast cancer.
Before leaving the University of Utah to assume the position of chief of the Genetic Epidemiology Unit at the International Association of Cancer Research in Lyon, France, Goldgar was a member of the team that led to the localization, cloning, or characterization of the cancer predisposing BRCA1, BRCA2, and CDKN2A (p16) mutations. Goldgar joined the CCPS Program in 2008 upon his return to the University of Utah.
Goldgar earned a bachelor's degree and PhD from the University of Colorado, Boulder.
|Doctoral Training||University of Colorado Medical Center
|Graduate Training||Colorado State University
|Undergraduate||University of Colorado
|Monash University||Honorary Faculty||Australia|
|Queensland Institute of Medical Resaerch||Visiting Scientist||Australia|
|Melbourne University||Honarary Professor||Australia|
|Laval University||Professeur Adjoint||Canada|
|Spanish National Cancer Institute||Visiting Scientist||Spain|
|International Agency for Research on Cancer, Unit of Genetic Epidemiology||Chief||United Kingdom|
- Vogl FD, Badzioch MD, Steele L, Neuhausen SL, Goldgar DE (2007). Risks of cancer due to a single BRCA1 mutation in an extended Utah kindred. Fam Cancer, 6(1), 63-71.
- Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, Goldgar DE (2007). An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res, 9(2), 104.
- Stratton MR, Ford D, Neuhausen S, Seal S, Wooster R, Friedman LS, King M-C, Egilsson V, Devilee P, McMarus R, Daly PA, Smith E, Ponder BAJ, Peto J, Cannon-Albright L, Easton D, Goldgar D (1994). Familial male breast cancer is not linked to BRCA1 locus on chromosome 17q. Nature Genetics, 7, 103-106.
- Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, Hegi ME, Wiseman RW, Petty EM, Bale AE, et al (1992). Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science, 258(5085), 1148-52.
- Goldgar DE, Cannon-Albright LA, Meyer LJ, Piepkorn MW, Zone JJ, Skolnick MH (1991). Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds. J Natl Cancer Inst, 83(23), 1726-33.